glp 1 receptor agonist drug names GLP-1 Agonists—commonly used for weight loss and diabetes—are now being linked to serious eye health concerns, including an increased risk of a condition called NAION, which can cause irreversible blindness. With GLP-1 Medication Options for Type 2
Description
Other experts are skeptical of this explanation
W., Schoenherr, J., Gouker, L
2014, 13:142 GLP-1R Signaling Binding of GLP-1 to GLP-1R triggers a downstream signaling cascade that induces a potent stimulation of glucose induced insulin secretion (GIIS) in pancreatic beta-cells, as well as inhibition of alpha cell glucagon release (6)
This has raised questions about potential conflicts of interest and highlights the importance of independent research
Less common risks include gallbladder disease and, in rare cases, pancreatitis
